Proactive Investors - GSK has done well enough since the Haleon consumer products arm was spun out last year, though after a decent run-up to the end of 2022, shares have gone a...
Newark, New Castle, USA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- As per the report published by Growth Plus Reports the Global Heparin Market was estimated at US$ 9.1 billion in 2021...
Proactive Investors - GSK PLC (LON:GSK) is growing at a "robust" rate and showing increasing confidence in its HIV treatments, according to Jefferies analysts, though they cut...
U.K.’s pharmaceutical stocks offer a buying opportunity in the current economic upheaval, given their defensive nature and the vast global footprint GSK has become a leaner...
A better than forecast, but still 2nd highest ever, UK borrowing figure for April failed to move the needle for the FTSE on Tuesday. The UK index was unchanged after the bell, flat...
The US is packing a lot into the final week of April, including a Fed meeting, some key Q1 data, and a stacked earnings calendar. US There are a few major events this week,...
GSK plc is a global biopharma company. The Company makes vaccines and specialty medicines to prevent and treat disease. Its segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed a new monoclonal antibody treatment for COVID-19. Its product areas include vaccines, specialty medicines, and general medicines. Its vaccine portfolio includes more than 20 vaccines that help protect people from a range of diseases and infections throughout their lives. Its specialty medicines include medicines for immune-mediated conditions, including the chronic autoimmune condition lupus, respiratory disease, and human immunodeficiency virus (HIV). Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease (COPD), antibiotics and medicines for skin diseases. It has a global network of about 12 vaccines manufacturing sites.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Neutral | Sell | Sell | Sell |
| Technical Indicators | Buy | Strong Sell | Sell | Sell | Strong Sell |
| Summary | Neutral | Sell | Sell | Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 50.30 | 50.30 | 48.45 | +1.20 | +2.44% | 970.50K | London | |||
| 20.10 | 20.30 | 20.00 | +0.15 | +0.75% | 624.19K | London | |||
| 112.30 | 115.00 | 112.30 | -2.20 | -1.92% | 2.17M | London | |||
| 132.00 | 132.00 | 132.00 | 0.00 | 0.00% | 0.00 | London | |||
| 7.70 | 7.70 | 7.70 | +0.190 | +2.50% | 12.59M | London | |||
| 110.20 | 112.30 | 108.30 | -3.28 | -2.89% | 63.80M | London | |||
| 316.90 | 319.50 | 310.50 | +8.90 | +2.89% | 3.83M | London | |||
| 342.00 | 350.00 | 340.20 | -4.60 | -1.33% | 634.43K | London | |||
| 2,688.00 | 2,688.00 | 2,638.00 | +42.0 | +1.59% | 303.20K | London | |||
| 1,371.50 | 1,381.50 | 1,357.50 | 0.00 | 0.00% | 3.75M | London | |||
| 832.60 | 838.00 | 824.60 | 0.00 | 0.00% | 0.00 | London | |||
| 29.55 | 29.10 | 29.00 | 0.00 | 0.00% | 0.00 | London | |||
| 185.78 | 185.98 | 184.30 | +0.74 | +0.40% | 21.99M | London | |||
| 170.20 | 172.70 | 167.80 | +3.60 | +2.16% | 669.44K | London | |||
| 422.00 | 424.00 | 419.50 | +1.00 | +0.24% | 793.14K | London |